Major clinical challenges exist with differentiated thyroid cancers with distant metastases or
rare but aggressive types, such as poorly differentiated thyroid carcinomas and anaplastic …

The genetic repertoire of primary thyroid cancers (TCs) is well documented, but there is a
considerable lack of molecular profiling in metastatic TCs. Here, we retrieved and analyzed …

Context Little is known about the frequency of key mutations in thyroid cancer metastases
and its relationship with the primary tumor genotype. Objectives To evaluate the frequency of …

Background: Distant metastases uncommonly occur in differentiated thyroid carcinoma
(DTC), but they are a frequent cause of thyroid cancer–related death. Genomic alterations in …

Background: Distant metastasis is a rare occurrence in thyroid cancer, and it can be
associated with poor prognosis. The genomic repertoires of various solid malignancies have …

Background TERT promoter mutations are associated with adverse clinicopathological
characteristics in thyroid carcinomas and considered as a major indicator of poor outcomes …

Papillary thyroid carcinoma (PTC) is the most common malignancy of the thyroid gland, with
a relatively high cure rate. Distant metastasis (DM) of PTC is uncommon, but when it occurs …

Context Clinical applications of genomic assessment of thyroid cancers are rapidly evolving.
Objectives, Design, and Setting We studied tumor samples from patients with imminently …

Thyroid carcinoma is the most common cancer in the endocrine system. Recent advances,
using next-generation sequencing, have shed light on the molecular pathogenesis of thyroid …

Background/Aim: Poorly differentiated thyroid carcinoma (PDTC), anaplastic thyroid
carcinoma (ATC), and advanced DTC have poor outcomes. Materials and Methods: We …